Your browser doesn't support javascript.
loading
Residual Tumor Index: A Prognostically Significant Pathologic Parameter in Neoadjuvant-treated Pancreatic Ductal Adenocarcinoma.
Panni, Roheena Z; Gonzalez, Ivan; Hartley, Christopher P; Williams, Gregory A; Liu, Jingxia; Hawkins, William G; Chatterjee, Deyali.
Afiliação
  • Panni RZ; Department of Surgery, Division of HPB and GI surgery.
  • Gonzalez I; Departments of Pathology and Immunology.
  • Hartley CP; Departments of Pathology and Immunology.
  • Williams GA; Department of Surgery, Division of HPB and GI surgery.
  • Liu J; Surgery, Division of Public Health, Section of Oncologic Biostatistics, Washington University in St. Louis, St. Louis, MO.
  • Hawkins WG; Department of Surgery, Division of HPB and GI surgery.
  • Chatterjee D; Departments of Pathology and Immunology.
Am J Surg Pathol ; 42(11): 1480-1487, 2018 11.
Article em En | MEDLINE | ID: mdl-30179901
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Pancreáticas / Terapia Neoadjuvante / Carcinoma Ductal Pancreático / Carga Tumoral Idioma: En Ano de publicação: 2018 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Pancreáticas / Terapia Neoadjuvante / Carcinoma Ductal Pancreático / Carga Tumoral Idioma: En Ano de publicação: 2018 Tipo de documento: Article